Interpace Biosciences

IDXG

OTCHealth Care

Income Statement

Total Revenue$16.5M

Gross Profit$6.11M

Operating Income$-12.01M

EBITDA$-9.38M

EBIT$-12.16M

Pre-tax Income$3.14M

Net Income$-12.47M

Cash Equivalent$2.65M

Total Debt$1.87M

Book Value$12.37M

Book Value Per Share6.13

Return on Equity (ROE)-363.41%

Return on Assets (ROA)+45.31%

Return on Invested Capital (ROI)-108.76%

Net Profit Margin+14.28%

Current Ratio1.11

Quick Ratio0.94

Long-Term Debt / Equity2.29